• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Visual outcomes in patients with neovascular age-related macular degeneration.

作者信息

Tan Colin S, Ngo Wei Kiong, Lim Louis W

机构信息

National Healthcare Group Eye Institute, Singapore, Singapore.

Fundus Image Reading Centre, National Healthcare Group Eye Institute, Singapore, Singapore.

出版信息

Acta Ophthalmol. 2018 Mar;96(2):e254. doi: 10.1111/aos.13540. Epub 2017 Aug 22.

DOI:10.1111/aos.13540
PMID:28834272
Abstract
摘要

相似文献

1
Visual outcomes in patients with neovascular age-related macular degeneration.新生血管性年龄相关性黄斑变性患者的视觉预后
Acta Ophthalmol. 2018 Mar;96(2):e254. doi: 10.1111/aos.13540. Epub 2017 Aug 22.
2
Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration.年龄相关性黄斑变性中脉络膜厚度与玻璃体内注射雷珠单抗反应之间的关联
Acta Ophthalmol. 2015 Sep;93(6):524-32. doi: 10.1111/aos.12653. Epub 2015 Jan 11.
3
ROLE OF ADDITIONAL DEXAMETHASONE FOR THE MANAGEMENT OF PERSISTENT OR RECURRENT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION UNDER RANIBIZUMAB TREATMENT.在雷珠单抗治疗下，额外使用地塞米松对持续性或复发性新生血管性年龄相关性黄斑变性的管理作用
Retina. 2017 May;37(5):962-970. doi: 10.1097/IAE.0000000000001264.
4
Choroidal Thickness Changes After Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration.玻璃体内注射雷珠单抗治疗渗出性年龄相关性黄斑变性后的脉络膜厚度变化。
BioDrugs. 2016 Aug;30(4):353-9. doi: 10.1007/s40259-016-0179-0.
5
INTRAVITREAL RANIBIZUMAB THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND THE RISK OF STROKE: A National Sample Cohort Study.玻璃体内注射雷珠单抗治疗新生血管性年龄相关性黄斑变性与中风风险：一项全国性样本队列研究。
Retina. 2016 Nov;36(11):2166-2174. doi: 10.1097/IAE.0000000000001084.
6
RETICULAR PSEUDODRUSEN ARE NOT A PREDICTIVE FACTOR FOR THE 1-YEAR RESPONSE TO INTRAVITREAL RANIBIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.在新生血管性年龄相关性黄斑变性中，网状假性玻璃膜疣并非玻璃体内注射雷珠单抗1年疗效的预测因素。
Retina. 2017 Jan;37(1):53-59. doi: 10.1097/IAE.0000000000001134.
7
INTRAVITREAL AFLIBERCEPT FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION UNRESPONSIVE TO RANIBIZUMAB THERAPY.玻璃体内注射阿柏西普治疗对雷珠单抗治疗无反应的年龄相关性黄斑变性所致脉络膜新生血管
Retina. 2016 Apr;36(4):770-7. doi: 10.1097/IAE.0000000000000751.
8
Intravitreal ranibizumab for naive extrafoveal choroidal neovascularization secondary to age-related macular degeneration.玻璃体内注射雷珠单抗治疗初发性年龄相关性黄斑变性继发的黄斑中心凹外脉络膜新生血管
Retina. 2014 Nov;34(11):2167-70. doi: 10.1097/IAE.0000000000000223.
9
Driving ability reported by neovascular age-related macular degeneration patients after treatment with ranibizumab.接受雷珠单抗治疗后，新生血管性年龄相关性黄斑变性患者的驾驶能力报告。
Ophthalmology. 2013 Jan;120(1):160-8. doi: 10.1016/j.ophtha.2012.07.027. Epub 2012 Sep 23.
10
LuceDex: a prospective study comparing ranibizumab plus dexamethasone combination therapy versus ranibizumab monotherapy for neovascular age-related macular degeneration.鲁西达单抗：一项比较雷珠单抗联合地塞米松联合治疗与雷珠单抗单药治疗新生血管性年龄相关性黄斑变性的前瞻性研究。
Retina. 2013 Sep;33(8):1600-4. doi: 10.1097/IAE.0b013e318285cb71.